Anticorps Recombinant de lapin anti-BAG3
BAG3 Recombinant Antibody for WB, IHC, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IHC, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
CloneNo.
240860F12
N° de cat : 83779-4-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
83779-4-PBS cible BAG3 dans les applications de WB, IHC, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | BAG3 Protéine recombinante Ag0956 |
Nom complet | BCL2-associated athanogene 3 |
Masse moléculaire calculée | 61 kDa |
Poids moléculaire observé | 74-80 kDa |
Numéro d’acquisition GenBank | BC006418 |
Symbole du gène | BAG3 |
Identification du gène (NCBI) | 9531 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
BAG3 (Bcl2-associated athanogene 3) belongs to the BAG protein family, the co-chaperone that binds to Hsc70/Hsp70 through the BAG domain and modulates their activity in polypeptide folding. BAG3 contains also a WW domain and a proline-rich (PXXP) repeat, that mediate binding to partners different from Hsp70. Through interacting with different molecular partner, BAG3 influences several cell processes, such as apoptosis, autophagy and cell motility. BAG3 protein has been reported to sustain cell survival, resistance to therapy, and/or motility and metastatization in several tumor types, thus being identified as a potential target for anticancer therapies. In addition, defects in BAG3 are the cause of some myopathy. BAG3 normally migrates around 74-80 kDa; a slightly different molecular weight or a doublet form can be observed in some cell types and/or following cell exposure to stressors. A synaptosome associated form of 40 kDa has recently been described.